Clinical trial
Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure (ADAM [Amlodipine and Dialysis Patients, Action on Mortality])
NCT00124969 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure (ADAM [Amlodipine and Dialysis Patients, Action on Mortality])
- Lead sponsor
- Charite University, Berlin, Germany
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- October 31, 2006
- Enrollment
- 356 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.